NGS Sample Preparation Market: Transforming Genomics with Rapid Growth

The NGS Sample Preparation Market is reshaping the way genomics is studied and applied in diagnostics, drug discovery, and research. With advancements in sequencing technology, the market is projected to witness remarkable growth, supported by rising genomic research, increasing cancer cases, and the demand for faster, more accurate diagnostic tools.

📥 Download Sample

The global NGS sample preparation market size was valued at USD 2.11 billion in 2024 and is set to expand from USD 2.41 billion in 2025 to reach USD 7.03 billion by 2033, growing at a strong CAGR of 14.32% (2025–2033). This growth is being fueled by continuous improvements in sequencing technologies, their adoption in clinical practice, and the rising prevalence of cancer worldwide.

Market Growth Drivers

• Alternative to PCR and Multi-Gene Detection: NGS is proving to be a faster and more cost-effective tool for diagnostics, with the ability to identify multiple gene alterations at once. The European Society for Medical Oncology (ESMO) has already recommended NGS in the treatment of cancers like NSCLC, cholangiocarcinoma, ovarian, and prostate cancer.
• Surge in Genomic Research: Increasing global initiatives in genome studies are helping accelerate disease diagnosis and infectious disease monitoring. Whole genome and exome sequencing have become clinically useful due to reduced processing time.

Restraints

Despite its potential, the risk of discovering variants of unknown significance (VUS) poses a challenge. This makes expert interpretation critical, often leading to uncertainties in patient care.

Opportunities

The rising global cancer burden is creating a strong need for rapid and accurate diagnostic tools. According to the International Agency for Research on Cancer (IARC), 19.3 million new cancer cases and 10 million cancer deaths were reported in 2020, underlining the demand for advanced sequencing-based solutions.

Regional Insights

North America dominates the market due to strong government and private sector support, a growing number of NGS-based clinical applications, cancer research initiatives, and the presence of key service providers.

Product and Application Trends

• Products: Divided into instruments and reagents & consumables, with reagents further segmented into library preparation, target enrichment, and quality control.
• Applications: Diagnostics lead the market, driven by rising cancer cases, wider insurance coverage for NGS-based tests in the U.S., and increasing focus on reproductive health and infectious disease testing.

Key Players in the NGS Sample Preparation Market

• Thermo Fisher Scientific, Inc.
• QIAGEN
• Hoffmann-La Roche Ltd.
• Merck KGaA
• Promega Corporation
• Agilent Technologies
• Integrated DNA Technologies, Inc.
• Illumina, Inc.
• Tecan Trading AG
• New England Biolabs

Recent Developments

• 2020: New England Biolabs launched NEBNext Custom RNA depletion design tool.
• 2020: 10x Genomics and Merck partnered to integrate single-cell transcriptomics with CRISPR screening.
• 2020: Illumina released free software to aid COVID-19 research.
• 2019: Agilent introduced advanced NGS library preparation systems.
• 2018: Thermo Fisher launched Oncomine Childhood Cancer Research Assay.

Conclusion

The NGS Sample Preparation Market is on a strong growth trajectory, powered by technological advancements, rising cancer cases, and broader adoption in diagnostics and research. With continuous innovations and expanding applications, the market is expected to play a crucial role in shaping the future of personalized medicine and healthcare.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)

Website: https://straitsresearch.com/